Enovix Co. (NASDAQ:ENVX) Given Consensus Rating of “Moderate Buy” by Analysts

Enovix Co. (NASDAQ:ENVXGet Free Report) has earned a consensus rating of “Moderate Buy” from the eleven research firms that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $20.30.

A number of equities research analysts have recently weighed in on ENVX shares. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective on the stock. in a report on Thursday, October 31st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research report on Thursday, February 20th. Craig Hallum dropped their target price on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Finally, Benchmark reaffirmed a “buy” rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th.

Check Out Our Latest Report on Enovix

Insider Buying and Selling at Enovix

In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Enovix

A number of hedge funds have recently added to or reduced their stakes in ENVX. Private Advisor Group LLC increased its holdings in Enovix by 23.6% in the third quarter. Private Advisor Group LLC now owns 99,900 shares of the company’s stock worth $933,000 after buying an additional 19,056 shares during the last quarter. Legacy Capital Group California Inc. grew its holdings in Enovix by 47.3% during the third quarter. Legacy Capital Group California Inc. now owns 28,022 shares of the company’s stock valued at $262,000 after purchasing an additional 8,998 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Enovix by 34.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 20,077 shares of the company’s stock valued at $188,000 after purchasing an additional 5,162 shares during the last quarter. Voisard Asset Management Group Inc. grew its holdings in Enovix by 40.0% during the third quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock valued at $65,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Gladstone Institutional Advisory LLC grew its holdings in Enovix by 1.9% during the third quarter. Gladstone Institutional Advisory LLC now owns 189,115 shares of the company’s stock valued at $1,766,000 after purchasing an additional 3,525 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Stock Down 8.4 %

Shares of NASDAQ ENVX opened at $9.82 on Thursday. Enovix has a 12-month low of $5.70 and a 12-month high of $18.68. The stock has a market cap of $1.75 billion, a PE ratio of -6.77 and a beta of 1.87. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The company has a 50-day moving average of $11.17 and a 200 day moving average of $10.28.

Enovix (NASDAQ:ENVXGet Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The firm had revenue of $9.72 million for the quarter, compared to analyst estimates of $8.77 million. As a group, sell-side analysts predict that Enovix will post -1.01 EPS for the current fiscal year.

About Enovix

(Get Free Report

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.